208 related articles for article (PubMed ID: 29286169)
21. Identification and validation of potential novel biomarkers for oral squamous cell carcinoma.
Zhang M; Chen X; Chen H; Zhou M; Liu Y; Hou Y; Nie M; Liu X
Bioengineered; 2021 Dec; 12(1):8845-8862. PubMed ID: 34606406
[TBL] [Abstract][Full Text] [Related]
22. Molecular Pathogenesis of the Coronin Family:
Kase-Kato I; Asai S; Minemura C; Tsuneizumi K; Oshima S; Koma A; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884487
[TBL] [Abstract][Full Text] [Related]
23. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
25.
Zhang J; Wu J; Chen Y; Zhang W
Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
[TBL] [Abstract][Full Text] [Related]
26. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y
Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001
[TBL] [Abstract][Full Text] [Related]
28. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
29. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.
Liu Z; Li H; Fan S; Lin H; Lian W
Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566
[TBL] [Abstract][Full Text] [Related]
30. MiR-802 inhibits the malignant biological behavior of oral squamous cell carcinoma by targeting proto-oncogene MET.
Xu HY; Dai Q; Chen QX; Xiao F; Dai YH
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4255-4262. PubMed ID: 32373961
[TBL] [Abstract][Full Text] [Related]
31. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
[TBL] [Abstract][Full Text] [Related]
32. IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.
Gao L; Wang X; Wang X; Zhang L; Qiang C; Chang S; Ren W; Li S; Yang Y; Tong D; Chen C; Li Z; Song T; Zhi K; Huang C
Oncotarget; 2014 May; 5(9):2562-74. PubMed ID: 24810113
[TBL] [Abstract][Full Text] [Related]
33. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
[TBL] [Abstract][Full Text] [Related]
34. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
35. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
36. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
37. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
38. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
39. Role of c-Met in the progression of human oral squamous cell carcinoma and its potential as a therapeutic target.
Sun Z; Liu Q; Ye D; Ye K; Yang Z; Li D
Oncol Rep; 2018 Jan; 39(1):209-216. PubMed ID: 29115556
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway.
He J; Ye W; Kou N; Chen K; Cui B; Zhang X; Hu S; Liu T; Kang L; Li X
J Cell Mol Med; 2020 Jan; 24(1):841-849. PubMed ID: 31680452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
